Form 4: Clorox Director Boosts Stake with Deferred Stock Units

Clorox Director Stephanie Plaines increased her beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment and director fees.

Summary

• Stephanie Plaines, a Director of The Clorox Company, acquired additional Deferred Stock Units (DSUs).
• On August 29, 2025, she acquired 53.9884 DSUs through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
• On September 30, 2025, she acquired 212.8954 DSUs in lieu of quarterly director's fees.
• Following these transactions, her total beneficial ownership of DSUs stands at 5,413.1984.
• These DSUs will be settled 100% in Clorox common stock upon her retirement or termination of service as a Director.

Sentiment

Score: 7

Explanation: The filing indicates a director increasing their stake in the company through routine compensation and dividend reinvestment, which is generally a positive signal of confidence, though not a direct cash investment.

Positives

• Director Stephanie Plaines increased her beneficial ownership in Clorox, aligning her interests further with shareholders.
• The acquisition of Deferred Stock Units through dividend reinvestment demonstrates a long-term commitment to the company.
• Receiving director's fees in DSUs instead of cash indicates confidence in the company's future stock performance.

Risks

• The value of the Deferred Stock Units is subject to the future market price of Clorox common stock.

Future Outlook

The Deferred Stock Units will be settled 100% in Clorox common stock upon the reporting person's retirement or other termination of service as a Director, indicating a long-term vesting and ownership structure.

Management Comments

• The acquisition of Deferred Stock Units through dividend reinvestment aligns with the Independent Directors' Deferred Compensation Plan.
• Receipt of Deferred Stock Units in lieu of quarterly director's fees reflects a choice to defer cash compensation for equity.

Industry Context

Insider buying, even through deferred compensation plans, is generally viewed positively as it signals management's confidence in the company's future performance. This is a standard practice for director compensation in many publicly traded companies, aligning director interests with long-term shareholder value.

Comparison to Industry Standards

• The practice of compensating directors with deferred stock units is a common corporate governance mechanism across various industries, including consumer staples, to align director incentives with long-term shareholder value. Companies like Procter & Gamble (PG) and Kimberly-Clark (KMB) also utilize similar equity-based compensation structures for their non-employee directors.
• Dividend reinvestment plans for directors are also standard, allowing for compounding equity ownership without direct cash outlay.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with long-term shareholder value due to increased equity ownership.

Next Steps

• The Deferred Stock Units will convert to Clorox common stock upon the reporting person's retirement or termination of service.

Key Dates

Recommendation

This Form 4 filing details routine acquisitions of Deferred Stock Units by a director as part of their compensation and dividend reinvestment plan. While it signals confidence from an insider, it does not represent a significant new investment or change in company fundamentals that would warrant a change in investment recommendation. It's an expected governance practice.

Keywords

Clorox, CLX, Form 4, Insider Transaction, Director Stock Acquisition, Deferred Stock Units, Dividend Reinvestment, Corporate Governance